Wuxi Pharmatech (Cayman) Inc., of Shanghai, said it established a representative office in the Tel Aviv area of Israel, aimed at promoting Wuxi's platform of integrated R&D services to local customers. It also will collaborate with Pontifax, a health care-dedicated venture capital firm based in Israel, to invest in technologies in the region, particularly those that can advance Wuxi's capabilities.